Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bio-Rad Laboratories (BIO)

603.99   1.42 (0.24%) 04-13 09:35
Open: 602.05 Pre. Close: 602.57
High: 606.27 Low: 599.02
Volume: 87,101 Market Cap: 17,908M
Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 606.998 - 609.332 609.332 - 611.666
Low: 592.889 - 595.735 595.735 - 598.581
Close: 599.442 - 603.76 603.76 - 608.079

Technical analysis

as of: 2021-04-12 4:50:17 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 708.12     One year: 827.09
Support: Support1: 569.78    Support2: 547.22
Resistance: Resistance1: 606.27    Resistance2: 708.12
Pivot: 578.61
Moving Average: MA(5): 592.60     MA(20): 575.74
MA(100): 583.97     MA(250): 533.98
MACD: MACD(12,26): 3.47     Signal(9): -1.43
Stochastic oscillator: %K(14,3): 96.37     %D(3): 87.60
RSI: RSI(14): 60.27
52-week: High: 689.00  Low: 396.16  Change(%): 48.9
Average Vol(K): 3-Month: 21173  10-Days: 12296

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BIO has closed below upper band by 2.3%. Bollinger Bands are 30.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 13 Apr 2021
Hydrophobic Interaction Chromatography Market Poised for Growth | Key Players – Bio-Rad Laboratories, Inc., Sartorius AG. – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper

Tue, 13 Apr 2021
Genetic Material Market Detailed Study Mentioning Positive Growth | Players – Abbott Laboratories., Bio-Rad Laboratories, Inc., Myriad Genetics. - KSU | The Sentinel Newspaper

Tue, 13 Apr 2021
Reporter Tags Market to eyewitness Huge Growth till 2027, Key Players – Bio-Rad Laboratories, Inc., Promega Corporation. – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper

Tue, 13 Apr 2021
Cell Counting Devices Market Excellent Revenue till 2027, Key Players – Bio-Rad Laboratories, Inc., GE Healthcare. – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper

Mon, 12 Apr 2021
Bio-Rad Laboratories - Consensus Indicates Potential 27.1% Upside - DirectorsTalk Interviews

Fri, 09 Apr 2021
10x Genomics, Bio-Rad Laboratories Subsidiary Celsee Headed to Trial in Single-Cell IP Suit - GenomeWeb

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 25
Shares Float (M) 21
% Held by Insiders 14.35
% Held by Institutions 81.21
Shares Short (K) 555
Shares Short P. Month (K) 617

Stock Financials

EPS 126.200
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 331.050
Profit Margin 149.52
Operating Margin 16.06
Return on Assets (ttm) 2.4
Return on Equity (ttm) 48.7
Qtrly Rev. Growth 26.5
Gross Profit (p.s.) 58.135
Sales Per Share 102.947
EBITDA (p.s.) 22.078
Qtrly Earnings Growth 51.60
Operating Cash Flow (M) 575
Levered Free Cash Flow (M) 429

Stock Valuations

PE Ratio 4.79
PEG Ratio
Price to Book value 1.82
Price to Sales 5.87
Price to Cash Flow 26.00

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.